1. 16/#430 Phase 2 results of relacorilant + nab-paclitaxel in patients with recurrent, platinum-resistant ovarian cancer with and without prior bevacizumab. (4th December 2022) Authors: Colombo, Nicoletta; Gorp, Toon Van; Matulonis, Ursula; Oaknin, Ana; Grisham, Rachel; Fleming, Gini; Olawaiye, Alexander; Tudor, Iulia Cristina; Pashova, Hristina; Lorusso, Domenica Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-660-ESGO Characterization of extended treatment benefit from three phase 1 and 3 clinical trials examining patients with folate receptor alpha-positive recurrent ovarian cancer treated with single-agent mirvetuximab soravtansine. (20th October 2022) Authors: Oaknin, Ana; Lorusso, Domenica; Oza, Amit; Colombo, Nicoletta; van Gorp, Toon; O'Malley, David; Banerjee, Susana; Murphy, Conleth; Harter, Philipp; Konecny, Gottfried; Kaminsky, Marie-Christine; Method, Michael; Wang, Jiuzhou; Coleman, Robert L; Birrer, Michael; Matulonis, Ursula; Moore, Kathleen Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 418 A phase 1, dose escalation and dose expansion study of SQZ PBMC HPV as monotherapy and in combination with atezolizumab in HLA-A*02+ Patients with HPV16+ recurrent, or metastatic solid tumors. (10th December 2020) Authors: Eng, Cathy; Baranda, Joaquina; Taylor, Matthew; Gordon, Michael; Matulonis, Ursula; Janku, Filip; Kornacker, Martin; Kamat, Asha; Rosen, Oliver; Jimeno, Antonio; Eng, Cathy Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 418 A phase 1, dose escalation and dose expansion study of SQZ PBMC HPV as monotherapy and in combination with atezolizumab in HLA-A*02+ Patients with HPV16+ recurrent, or metastatic solid tumors. (9th November 2020) Authors: Eng, Cathy; Baranda, Joaquina; Taylor, Matthew; Gordon, Michael; Matulonis, Ursula; Janku, Filip; Kornacker, Martin; Kamat, Asha; Rosen, Oliver; Jimeno, Antonio; Eng, Cathy Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Anti-CCR4 monoclonal antibody enhances antitumor immunity by modulating tumor-infiltrating Tregs in an ovarian cancer xenograft humanized mouse model. (3rd March 2016) Authors: Chang, De-Kuan; Peterson, Eric; Sun, Jiusong; Goudie, Calum; Drapkin, Ronny I.; Liu, Joyce F.; Matulonis, Ursula; Zhu, Quan; Marasco, Wayne A. Journal: Oncoimmunology Issue: Volume 5:Number 3(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Differential blood count as triage tool in evaluation of pelvic masses. Issue 5 (2nd June 2020) Authors: Cramer, Daniel W; Benjamin IV, William J; Vitonis, Allison F; Berkowitz, Ross; Goodman, Annekathryn; Matulonis, Ursula Journal: International journal of gynecological cancer Issue: Volume 31:Issue 5(2021) Page Start: 733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Differential blood count as triage tool in evaluation of pelvic masses. Issue 5 (2nd June 2020) Authors: Cramer, Daniel W; Benjamin IV, William J; Vitonis, Allison F; Berkowitz, Ross; Goodman, Annekathryn; Matulonis, Ursula Journal: International journal of gynecological cancer Issue: Volume 31:Issue 5(2021) Page Start: 733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Differential blood count as triage tool in evaluation of pelvic masses. Issue 5 (May 2021) Authors: Cramer, Daniel W; Benjamin, William J; Vitonis, Allison F; Berkowitz, Ross; Goodman, Annekathryn; Matulonis, Ursula Journal: International journal of gynecological cancer Issue: Volume 31:Issue 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy. Issue 9 (30th October 2018) Authors: Friedlander, Michael; Matulonis, Ursula; Gourley, Charlie; du Bois, Andreas; Vergote, Ignace; Rustin, Gordon; Scott, Clare; Meier, Werner; Shapira-Frommer, Ronnie; Safra, Tamar; Matei, Daniela; Shirinkin, Vadim; Selle, Frédéric; Fielding, Anitra; Lowe, Elizabeth; McMurtry, Emma; Spencer, Stuart; ... Journal: British journal of cancer Issue: Volume 119:Issue 9(2018) Page Start: 1075 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Multiple Myeloma Masquerading as Ovarian Carcinosarcoma Metastases: A Case Report and Review of the Approach to Multiple Myeloma Screening and Diagnosis. (24th September 2018) Authors: Stuver, Robert; Petersen, Alec; Guerrero-Garcia, Thomas A.; Matulonis, Ursula; Richardson, Paul; Singh, Prabhsimranjot Other Names: Ohsaka Akimichi Academic Editor. Journal: Case reports in hematology Issue: Volume 2018(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗